Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis
Top Cited Papers
- 1 October 2006
- journal article
- research article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 119 (10), 812-819
- https://doi.org/10.1016/j.amjmed.2006.02.031
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring StudyCirculation, 2004
- Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and WomenArchives of Internal Medicine, 2004
- The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality StudyAtherosclerosis, 2004
- Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in WomenCirculation, 2004
- Which Features of the Metabolic Syndrome Predict the Prevalence and Clinical Outcomes of Angiographic Coronary Artery Disease?JMIR AI, 2004
- The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications StudyDiabetic Medicine, 2003
- Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention StudyCirculation, 2003
- Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluationAtherosclerosis, 2002
- Comment on the provisional report from the WHO consultationDiabetic Medicine, 1999
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986